What's in it?
Search Entire CPID Database
Enter Products, Manufacturers, Chemicals, Product Categories and Product Types
You may also search by:
In case of poisoning, immediately contact your 24-Hour Poison Control Hotline at : 1-800-222-1222 in U.S.A.
First Aid Information For: Bonide Fruit Tree Spray Concentrate-1/14/2002-Old Product
GENERAL: If known exposure occurs or if poisoning is suspected, DO NOT WAIT FOR SYMPTOMS TO DEVELOP. Immediately start the procedures recommended below and simultaneously contact a Poison Control Center, a physician or the nearest hospital, inform the person contacted of the type and extent of exposure, describe the victim's symptoms, and follow the advice given.
SKIN: Wash the material off the skin with plenty of soap and water. If redness, itching or a burning sensation develops, get medical attention. Wash any contaminated clothing and decontaminate footwear before reuse.
EYES: Immediately flush eyes with plenty of water. After initial flushing, remove any contact lenses and continue flushing for at least 15 minutes. Have eyes examined and treated by medical personnel as soon as possible.
INGESTION: Do not induce vomiting. Aspiration hazard exists if swallowed or if vomiting occurs; product can enter lungs and cause damage. Call a physician or Poison Control Center immediately.
INHALATION: Remove victim to fresh air. Contact medical personnel if a cough or other respiratory symptoms develop. If not breathing, give artificial respiration, preferably mouth-to-mouth. If breathing is labored, give oxygen. Consult medical personnel.
NOTES TO PHYSICIAN: Contains an aromatic petroleum solvent, vomiting may cause aspiration pneumonia. Product also contains two active ingredients which are cholinesterase inhibitors affecting the central and peripheral nervous systems and producing cardiac and respiratory depression. Atropine sulfate in large doses is an antidote. Two to four mg intravenously or intramuscularly as soon as cyanosis is overcome. Repeat at 5 to 10 minute intervals until signs of atropinization appear. 2-PAM chloride is a pharmacological antidote. DO NOT GIVE MORPHINE OR TRANQUILLIZERS. At first sign of pulmonary edema, the patient should be given supplemental oxygen and treated symptomatically. MSDS/Label: Continued absorption of malathion may occur and relapse may occur after initial improvement. VERY CLOSE SUPERVISION OF THE PATIENT IS INDICATED FOR AT LEAST 48 HOURS. MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE: Any disease, medication or prior exposure, which reduces normal cholinesterase activity, may increase the susceptibility to the toxic effects of the active ingredients. Pre-existing skin, eye, liver, kidney, nervous system or respiratory disorders may be aggravated by excessive overexposure. Skin irritation may be aggravated in persons with existing skin lesions. Overexposure may aggravate existing chronic cardiovascular or respiratory disease, leading to respiratory difficulty, pulmonary edema and cyanosis. Exposure to cholinesterase inhibitors should be restricted in persons with hemolytic anemias or preexisting cholinesterase inhibition.
SKIN: Wash the material off the skin with plenty of soap and water. If redness, itching or a burning sensation develops, get medical attention. Wash any contaminated clothing and decontaminate footwear before reuse.
EYES: Immediately flush eyes with plenty of water. After initial flushing, remove any contact lenses and continue flushing for at least 15 minutes. Have eyes examined and treated by medical personnel as soon as possible.
INGESTION: Do not induce vomiting. Aspiration hazard exists if swallowed or if vomiting occurs; product can enter lungs and cause damage. Call a physician or Poison Control Center immediately.
INHALATION: Remove victim to fresh air. Contact medical personnel if a cough or other respiratory symptoms develop. If not breathing, give artificial respiration, preferably mouth-to-mouth. If breathing is labored, give oxygen. Consult medical personnel.
NOTES TO PHYSICIAN: Contains an aromatic petroleum solvent, vomiting may cause aspiration pneumonia. Product also contains two active ingredients which are cholinesterase inhibitors affecting the central and peripheral nervous systems and producing cardiac and respiratory depression. Atropine sulfate in large doses is an antidote. Two to four mg intravenously or intramuscularly as soon as cyanosis is overcome. Repeat at 5 to 10 minute intervals until signs of atropinization appear. 2-PAM chloride is a pharmacological antidote. DO NOT GIVE MORPHINE OR TRANQUILLIZERS. At first sign of pulmonary edema, the patient should be given supplemental oxygen and treated symptomatically. MSDS/Label: Continued absorption of malathion may occur and relapse may occur after initial improvement. VERY CLOSE SUPERVISION OF THE PATIENT IS INDICATED FOR AT LEAST 48 HOURS. MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE: Any disease, medication or prior exposure, which reduces normal cholinesterase activity, may increase the susceptibility to the toxic effects of the active ingredients. Pre-existing skin, eye, liver, kidney, nervous system or respiratory disorders may be aggravated by excessive overexposure. Skin irritation may be aggravated in persons with existing skin lesions. Overexposure may aggravate existing chronic cardiovascular or respiratory disease, leading to respiratory difficulty, pulmonary edema and cyanosis. Exposure to cholinesterase inhibitors should be restricted in persons with hemolytic anemias or preexisting cholinesterase inhibition.